|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| Footcare Products in the U.S. |
|
|
|
|
€ 1 596,00 |
Editeur
: |
Packaged Facts |
Langue
: |
Anglais |
Date de publication : |
Mai 2007 |
Taille du document : |
118 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players 87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand |
1 520,00 €
|
| |
| |
OTC Pharmaceuticals in China 151 pages | Novembre 2002 |
This new report on the market for over-the-counter (OTC) pharmaceuticals in the People’s Republic of China. The report covers the following sectors: Analgesics, Cough, cold and allergy (hay-fever) |
1 065,00 €
|
| |
| |
US First Aid 2004 16 pages | Juillet 2004 |
Snapdata's US First Aid 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US first aid market, and covers trea |
240,00 €
|
| |
| |
US Mineral Supplements 2004 12 pages | Novembre 2004 |
Snapdata's US Mineral Supplements 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US mineral supplement mark |
240,00 €
|
| |
| |
UK Analgesics 2004 12 pages | Juillet 2004 |
Snapdata's UK Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the UK analgesic market, and covers non |
240,00 €
|
| |
| |
US Family Planning 2004 12 pages | Novembre 2004 |
Snapdata's US Family Planning 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US family planning market, and |
240,00 €
|
| |
| |
Poland Contraceptives 2004 12 pages | Juillet 2004 |
Snapdata's Poland Contraceptives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the Polish contraceptive market |
240,00 €
|
| |
| |
US Acne Treatments 2004 14 pages | Juillet 2004 |
Snapdata's US Acne Treatments 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US acne treatments market.
|
240,00 €
|
| |
| |
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players 87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand |
2 443,75 €
|
| |
| |
US Cough Cold & Throat Remedies 2004 16 pages | Juillet 2004 |
Snapdata's US Cough Cold & Throat Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US cough, cold an |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Footcare Products in the U.S. |
|
|
The third edition Packaged Facts report, Foot Care Products in the U.S., is an analysis of the various brands and marketers, key issues and trends, and marketing dynamics within the OTC mass market foot care medication and device industry. This formerly flat-footed market has hit its stride. In 2006, foot care market sales increased for the first time in several years, with a 5.7% rise in dollar sales and a 3.5% bump in volume sales over the level seen in 2005. Several factors have converged to drive this growth. Consumer interest in private-label products; a large Baby Boomer population with associated aches and pains of aging; clinical product innovations to serve the needs of diabetics and alternately, spa-like product innovations to serve consumers interested in pampering their feet will continue to push the market forward to an estimated $900 million by 2011. The market may reach even greater heights if the players step up their advertising and promotional budgets.
This report covers the sale of foot care products through channels covered by Information Resources, Inc., including private label, and provides a growth estimates for overall market. Topics covered also include: Trends and Factors to Growth that will drive the market; an overview of new product innovation, advertising spend, and current promotional activity; profiles of top marketers; and a consumer usage and psychographic analysis.
Plus, you’ll benefit from extensive data, presented in easy-to-read and practical charts, tables and graphs.
How You Will Benefit from this Report If your company is already competing in the foot care industry, or is considering making the leap, you will find this report invaluable, as it provides a comprehensive package of information and insight not offered in any other single source. You will gain a thorough understanding of the current market for foot care products, as well as projected sales and trends through 2011. Contributing to that understanding will be a complete analysis of sales data, and a detailed discussion of the consumer for foot care products based on Simmons data.
This report will help:
Marketing Managers identify market opportunities and develop targeted promotion plans for foot care products. Research and development professionals stay on top of competitor initiatives and explore demand for foot care products. Advertising agencies working with clients in the personal care industry understand the product buyer to develop messages and images that compel consumers to purchase foot care products. Business development executives understand the dynamics of the market and identify possible partnerships. Information and research center librarians provide market researchers, brand and product managers and other colleagues with the vital information they need to do their jobs more effectively.
|
|
Chapter 1 Executive Summary
Scope Methodology Product Categories and Segments Foot Care Devices Foot Care Medications The Overall Market Foot Care Kickin’ with 5.7% Sales Growth Figure 1-1 U.S. Retail Sales of Foot Care Products, 2002-2006 (in million $) Devices and Medications Growing on Parallel Paths in 2006 Figure 1-2 U.S. Retail Sales Trends by Foot Care Category, 2002-2006 (in million $)
Growth Factors Strong Private Label Competition The Value of the Boomer Diabetes, a National Problem Creating a Spa Experience The Health and Beauty Invasion Broadening Foot Care Appeal to Women Increasing Accessibility: Expanding Beyond Mass and Drug
Foot Care Market Growth Forecast Foot Care to Surpass $900 Million by 2011 Figure 1-3 Projected U.S. Retail Foot Care Market Sales, 2006-2011 (in million $)
The Brands and Marketers Market Overall Dr. Scholl’s the Clear Leader Figure 1-4 Foot Care Sales by Marketer, 2006 (%) Implus and Del Labs Break Out Performance Foot Care Devices Schering-Plough Dominates Devices Figure 1-5 Percentage IRI-Tracked Dollar Sales by Marketer: Foot Care Devices, 2006 Limited Star Performances in Devices Dr Scholl’s Brand Hard to Ignore Foot Care Medication Schering Plough Continues to Rule Medication Del Labs a Stand Out in Medication Figure 1-6 Percentage IRI-Tracked Dollar Sales by Marketer, Medication, 2006 Competition Among the Top Foot Care Medication Brands
Marketing Dynamics Foot Care Industry Light on Marketing Lamisil by Novartis Top 2005 Ad Spender TV Dominates Sponsorships In Store Opportunity Marketing Packaging New Entrants Novartis and Del Labs Stand Out with New Medications Private Label Differentiates with New Devices
The Consumer Toughing It Out To See the Doctor or Not to See the Doctor. That is the Question. Table 1-3 Percentage of Consumers Who Have Suffered Foot Care Ailments, 2003-2006 Table 1-4 Percentage of Consumers Who Have Used Prescription and Non-Prescription Foot Care Remedies, 2003-2006 Whose Feet are the Scariest? Most Report Mild to Moderate Severity Older Consumers More likely to Seek Treatment Education and Job Status a Factor Profile of an Athlete’s Foot Sufferer Profile of a Nail Fungus Sufferer Chapter 2 The Overall Foot Care Market
Scope Methodology Product Categories and Segments Foot Care Devices Foot Care Medications Market Size and Growth Foot Care Kickin’ with 5.7% Sales Growth Oh My Aching Feet! Figure 2-1 U.S. Retail Sales of Foot Care Products, 2002-2006 (in million $) Table 2-1 Foot Ailment Breakdown, 2006 (%)
Market Composition Devices and Medications Grow on Parallel Paths in 2006 Figure 2-3 U.S. Retail Sales Trends by Foot Care Category, 2002-2006 (in million $) Figure 2-4 Market Share of Foot Care Products by Category, 2002-2006 (%) Strong Private Label Competition Figure 2-5 U.S. Retail Sales Trends, Branded vs. Private Label Foot Care Devices, 2002-2006 (in million $) Figure 2-6 U.S. Retail Sales Trends, Branded vs. Private Label Foot Care Medication, 2002-2006 (in million $) Figure 2-7 Market Share of Branded U.S. Retail Sales by Foot Care Category, 2002-2006
Foot Care Growth Forecast Foot Care to Surpass $900 Million by 2011 Figure 2-8 Projected U.S. Retail Foot Care Market Sales, 2006-2011 (in million $) Chapter 3 Growth Factors
Private Label Booming Figure 3-1 U.S. Foot Care Retail Sales Growth, Branded vs. Private Label, 2002-2006 (in million $) Figure 3-2 Share of U.S. Foot Care Retail Sales, Branded vs. Private Label, 2002-2006 Keeping It Fresh More Face Time with Private Label The Value of the Boomer No Time for Aches and Pains Table 3-1 Projected U.S. Population, by Age Bracket, 2000-2020 (in thousands) Diabetes a National Problem… and Market Opportunity Figure 3-3 Percentage of Adults with Diabetes, 2005 Figure 3-4 Number of New Diabetes Cases Diagnosed in 2005 (in thousands) Creating a Spa Experience The Health and Beauty Invasion Broadening Foot Care Appeal to Women Sof Sole Energy—First Line of Foot Care Accessories Created Just for Women Increasing Accessibility: Expanding Beyond Mass and Drug Podiatry Services Department Stores Independent Retailers Chapter 4 Foot Care Brands and their Marketers
Overall Market Performance Table 4-1 IRI-Tracked Dollar Sales of Total Foot Care Products, 2002-2006 (in million $) Figure 4-1 IRI-Tracked Dollar Sales of Total Foot Care Products, 2002-2006 (in million $) Medication Growing Faster Than Devices Figure 4-2 Foot Care Sales by Category, 2002-2006 (in million $) Schering-Plough the Clear Leader Figure 4-3 Foot Care Sales by Marketer, 2006 (%) Implus and Del Labs’ Breakout Performance Figure 4-4 Foot Care Sales, Top 10 Marketers, 2004-2006 (in million $) Table 4-3 Foot Care Sales, Top 10 Marketers, 2002-2006 (in million $) By Brand, Dr Scholl’s Hot Figure 4-5 Top 10 Foot Care Brands by Sales, 2004-2006 (in million $) Table 4-4 Top 10 Foot Care Brands by Sales, 2002-2006 (in million $)
Foot Care Devices Category Size and Growth Schering-Plough Dominates Devices Figure 4-6 Percentage of Foot Care Device Sales by Top Marketers, 2006 Limited Star Performances in Devices Figure 4-7 Foot Care Device Sales, Top 10 Marketers, 2004-2006 (in million $) Table 4-5 Foot Care Device Sales, Top Ten Marketers, 2002-2006 (in million $) Table 4-6 Foot Care Device Sales Change, Top 10 Marketers, 2005 and 2006 (in million $ and %) Dr Scholl’s Hard to Ignore Figure 4-8 Top 10 Foot Care Device Brands by Sales, 2004-2006 (in million $) Table 4-7 Top 10 Foot Care Device Brands by Sales, 2002-2006 (in million $)
Foot Care Medication Category Size and Growth Schering-Plough Continues to Dominate Medication Del Labs a Stand Out in Medication Figure 4-9 Percentage of Foot Care Medication Sales by Top Marketers, 2006 (%) Figure 4-10 Foot Care Medication Sales, Top 10 Marketers, 2006 (in million $) Table 4-8 Foot Care Medication Sales, Top 10 Marketers, 2002-2006 (in million $) Competition Among the Top Foot Care Medication Brands Figure 4-11 Top Foot Care Medication Brands by Sales, 2004-2006 (in million $) Table 4-9 Top 10 Medication Brands by Sales, 2002-2006 (in million $) Chapter 5 Corporate Profiles
Schering-Plough Overview Performance Figure 5-1 Schering-Plough Performance, Foot Care Products, 2002-2006 (in million $) Figure 5-2 Schering-Plough Foot Care Brand Sales, 2002-2006 (in million $) Recent Activity Novartis Overview Performance Figure 5-3 Novartis Performance, Foot Care Medication, 2002-2006 (in million $) Recent Activity
Combe Overview Performance Figure 5-4 Combe Performance, Foot Care Products, 2002-2006 (in million $) Recent Activity
ProFoot, Inc. Overview Performance Figure 5-5 ProFoot Performance, Foot Care Products, 2002-2006 (in million $) Recent Activity
Implus Footcare Overview Performance Figure 5-6 Implus Performance, Foot Care Products,* 2002-2006 (in million $) Recent Activity
Chattem Overview Performance Figure 5-7 Chattem Performance, Gold Bond, 2002-2006 (in million $) Recent Activity Overview Performance Figure 5-8 Del Labs Performance, Foot Care Products, 2002-2006 (in million $) Recent Activity
Alva-Amco Overview Performance Figure 5-9 Alva-Amco Performance, Foot Care Products,* 2002-2006 (in million $) Recent Activity
Pedifix Overview Figure 5-10 Pedifix Performance, Foot Care Products, 2002-2006 (in million $) Performance Recent Activity Chapter 6 Marketing Dynamics
Foot Care Industry Light on Marketing 2005 Foot Care Ad Spend Data Table 6-1 Advertising Spend for Foot Care Brands, 2005 Lamisil by Novartis Top Spender TV Dominates Sporting Sponsorships In-Store Opportunity Marketing Packaging An Upscale Climb Figure 6-1 New Lamisil Packaging Figure 6-2 Implus Foot Care Products For Active Individuals Stepping Up Women’s Products Figure 6-3 Sally Hansen Packaging Line Figure 6-4 Implus Foot Care Packaging Line for Women Figure 6-5 Dr Scholl’s for Her Value Promise at Odds With Spa Promise Figure 6-6 Pedifix Packaging Functional Benefits Still Reign New Entrants Novartis and Del Labs Stand Out with New Medications Figure 6-7 New Product Packaging Athletic Products Cross Over Table 6-2 New Products from Top 10 Foot Care Medication Companies, 2006 Private Label Stands Out with New Devices Pedifix and Implus Vying for the Upper-End Device Market Table 6-3 New Products from Top 10 Device Manufacturers, 2006 Chapter 7 The Consumer
Simmons Market Research Bureau Survey Toughing It Out Pain and Suffering Table 7-1 Foot Ailment Breakdown, 2006 (%) Table 7-2 Percentage of Consumers Reporting Foot Ailments Suffered over Past 12 Months, 2006 (%) To See or Not to See the Doctor. That is the Question Table 7-3 Percentage of Consumers Who Suffered Foot Care Ailments in the Last 12 Months, 2003-2006 Table 7-4 Percentage of Consumers Who Treated a Foot Ailment in the Last 12 Months, 2003-2006 Form Factor: Lube Me Up Table 7-5: Household Penetration Rates for First Aid/Antibiotic Remedies, by Form, 2003-2006 (%) Whose Feet are the Scariest? Most Report Mild to Moderate Severity Table 7-6 Consumers’ Level of Foot Ailment Severity, 2006 (%) Table 7-7 Percentage of Consumers Who Feel at Risk for Foot Ailments, 2003-2006 Older Consumers More likely to Seek Treatment Table 7-8 Index of Foot Ailments and Treatment Usage by Age, 2006 (%) Table 7-9 Willingness to Consult a Podiatrist, by Age and Gender, 2006 (%) West Coast a Breeding Ground for Foot Ailments? Education and Job Status a Factor Table 7-10 Key Demographic Indicators: Regional, Education, Employment and Income, 2006 Table 7-10 [Cont.] Key Demographic Indicators: Regional, Education, Employment and Income, 2006 Profile of an Athlete’s Foot Sufferer Profile of a Nail Fungus Sufferer
|
|
|
PPLSEN
|
|
|
|
|